LT2320739T - Farmacinės kompozicijos ir jų stabilizavimo būdai - Google Patents

Farmacinės kompozicijos ir jų stabilizavimo būdai

Info

Publication number
LT2320739T
LT2320739T LTEP09803270.9T LT09803270T LT2320739T LT 2320739 T LT2320739 T LT 2320739T LT 09803270 T LT09803270 T LT 09803270T LT 2320739 T LT2320739 T LT 2320739T
Authority
LT
Lithuania
Prior art keywords
stabilizing
methods
same
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
LTEP09803270.9T
Other languages
English (en)
Inventor
Rajeshwar Motheram
Gopal Krishna
Ding Min
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of LT2320739T publication Critical patent/LT2320739T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP09803270.9T 2008-08-01 2009-07-30 Farmacinės kompozicijos ir jų stabilizavimo būdai LT2320739T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8559408P 2008-08-01 2008-08-01
US9381008P 2008-09-03 2008-09-03
PCT/US2009/004399 WO2010014234A1 (en) 2008-08-01 2009-07-30 Pharmaceutical compositions and methods for stabilizing the same

Publications (1)

Publication Number Publication Date
LT2320739T true LT2320739T (lt) 2020-01-27

Family

ID=41610652

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP09803270.9T LT2320739T (lt) 2008-08-01 2009-07-30 Farmacinės kompozicijos ir jų stabilizavimo būdai

Country Status (21)

Country Link
US (4) US20100105743A1 (lt)
EP (1) EP2320739B1 (lt)
JP (4) JP2011529879A (lt)
KR (4) KR20160095206A (lt)
CN (2) CN106377501A (lt)
AU (1) AU2009277100B2 (lt)
BR (1) BRPI0917562B8 (lt)
CA (1) CA2732692C (lt)
CY (1) CY1122526T1 (lt)
DK (1) DK2320739T3 (lt)
EA (1) EA201170287A1 (lt)
ES (1) ES2770178T3 (lt)
HR (1) HRP20200136T1 (lt)
HU (1) HUE047692T2 (lt)
LT (1) LT2320739T (lt)
MX (1) MX2011001241A (lt)
NZ (1) NZ591204A (lt)
PL (1) PL2320739T3 (lt)
PT (1) PT2320739T (lt)
SI (1) SI2320739T1 (lt)
WO (1) WO2010014234A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110076334A1 (en) * 2009-09-30 2011-03-31 Robert Cook Methods and compositions for treatment of raynaud's phenomenon
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
WO2012051116A1 (en) * 2010-10-12 2012-04-19 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
JP2014509654A (ja) * 2011-04-01 2014-04-21 ザ メディシンズ カンパニー 脳卒中損傷の低減に使用するための短時間作用型ジヒドロピリジン(クレビジピン)
CN103134891A (zh) * 2011-11-30 2013-06-05 天津金耀集团有限公司 一种丁酸氯维地平含量和有关物质的测定方法
BR112015009291B1 (pt) 2012-10-26 2021-03-16 Chiesi Farmaceutici S.P.A uso de clevidipina para controle da pressão arterial e redução da dispneia na insuficiência cardíaca
CN103520104B (zh) * 2013-10-25 2015-08-26 北京蓝丹医药科技有限公司 丁酸氯维地平脂肪乳注射液及其制备方法
CN109776405A (zh) * 2019-03-07 2019-05-21 重庆安格龙翔医药科技有限公司 一种丁酸氯维地平杂质的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756779A (fr) * 1969-09-30 1971-03-01 Warner Lambert Pharmaceutical Solutions stables de cardenolides sensibles a l'oxydation
US4150744A (en) * 1976-02-27 1979-04-24 Smith & Nephew Pharmaceuticals Ltd. Packaging
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
US5651991A (en) * 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
SE9303744D0 (sv) 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
SE9804002D0 (sv) 1998-11-23 1998-11-23 Astra Ab New manufacturing process
JP2000247883A (ja) * 1999-02-23 2000-09-12 Fujisawa Pharmaceut Co Ltd ジヒドロピリジン系化合物を含有する内服用液剤
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
US6956048B2 (en) * 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US6680334B2 (en) * 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
JP2003104888A (ja) * 2001-09-28 2003-04-09 Taiyo Yakuhin Kogyo Kk ジヒドロピリジン誘導体の錠剤
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
JP4667867B2 (ja) * 2002-08-02 2011-04-13 メルク・シャープ・エンド・ドーム・コーポレイション 置換フロ[2,3−b]ピリジン誘導体
WO2004110368A2 (en) * 2003-06-06 2004-12-23 Merck & Co., Inc. Combination therapy for the treatment of hypertension
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
EP1813274B1 (en) * 2004-10-06 2009-12-16 Eisai R&D Management Co., Ltd. Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US20070196465A1 (en) * 2005-07-28 2007-08-23 George Bobotas Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
US7612102B2 (en) * 2006-04-18 2009-11-03 Ekr Therapeutics, Inc. Pre-mixed, ready-to-use pharmaceutical compositions

Also Published As

Publication number Publication date
AU2009277100B2 (en) 2015-05-28
KR20180059956A (ko) 2018-06-05
SI2320739T1 (sl) 2020-03-31
CA2732692C (en) 2019-12-24
US20120322836A1 (en) 2012-12-20
BRPI0917562A8 (pt) 2017-12-12
BRPI0917562A2 (pt) 2017-06-20
EP2320739B1 (en) 2019-11-27
HUE047692T2 (hu) 2020-05-28
WO2010014234A1 (en) 2010-02-04
BRPI0917562B8 (pt) 2021-05-25
MX2011001241A (es) 2011-08-03
CY1122526T1 (el) 2021-01-27
KR20160095206A (ko) 2016-08-10
US20190117660A1 (en) 2019-04-25
ES2770178T3 (es) 2020-06-30
US20230302002A1 (en) 2023-09-28
JP2011529879A (ja) 2011-12-15
NZ591204A (en) 2013-02-22
JP2015098472A (ja) 2015-05-28
EP2320739A4 (en) 2011-08-24
CN102186351A (zh) 2011-09-14
DK2320739T3 (da) 2020-02-24
CA2732692A1 (en) 2010-02-04
JP2016216501A (ja) 2016-12-22
BRPI0917562B1 (pt) 2021-04-06
HRP20200136T1 (hr) 2020-08-21
PL2320739T3 (pl) 2020-06-01
EA201170287A1 (ru) 2011-10-31
EP2320739A1 (en) 2011-05-18
KR20170051542A (ko) 2017-05-11
PT2320739T (pt) 2020-02-18
JP2017081980A (ja) 2017-05-18
KR20110059843A (ko) 2011-06-07
KR101946977B1 (ko) 2019-05-21
CN106377501A (zh) 2017-02-08
AU2009277100A1 (en) 2010-02-04
JP6537538B2 (ja) 2019-07-03
US20100105743A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL228817A0 (en) Pharmaceutical compounds
EP2240022A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en) Pharmaceutical compositions
HK1158528A1 (zh) 藥物製劑
EP2265731A4 (en) METHODS AND COMPOSITION FOR EVALUATING MEDICATION RESPONSE
EP2373681A4 (en) PHARMACEUTICAL COMPOSITIONS
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
PT2323623T (pt) Composições farmacêuticas
IL206594A (en) The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations
IL210226A (en) Azul compound and pharmaceutical preparations containing them
PT2320739T (pt) Composições farmacêuticas e métodos para estabilizar as mesmas
IL208387A0 (en) Pharmaceutical composition
HK1156844A1 (en) Pharmaceutical composition 271 271
IL203064B (en) A pharmaceutical preparation containing compound 11 - deoxy - prostaglandin and a method for stabilizing the compound
HK1145837A1 (en) Amide derivative and pharmaceutical composition containing the same
ZA201006224B (en) Pharmaceutical composition
EP2327406A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION
GB2464200B (en) Pharmaceutical composition
IL206487A0 (en) Pharmaceutical compositions
PL2379056T3 (pl) Stała kompozycja farmaceutyczna zawierająca co najmniej jeden środek stabilizujący
GB0817969D0 (en) Pharmaceutical composition
GB0800659D0 (en) Pharmaceutical Compositions
TWI365071B (en) Isoxazole derivatives and pharmaceutical compositions comprising the same